Interactive Computer Treatment for Panic Disorder

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
Florida State University
ClinicalTrials.gov Identifier:
NCT00063375
First received: June 25, 2003
Last updated: October 24, 2013
Last verified: October 2013
  Purpose

This study will develop an interactive computer-based version of cognitive behavioral therapy (CBT) and compare its effectiveness to book-based CBT for the treatment of panic disorder.


Condition Intervention Phase
Panic Disorder
Behavioral: Computer Based Cognitive Behavioral Therapy
Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Interactive Computer Treatment for Panic Disorder

Resource links provided by NLM:


Further study details as provided by Florida State University:

Estimated Enrollment: 60
Study Start Date: January 2002
Primary Completion Date: February 2007 (Final data collection date for primary outcome measure)
Detailed Description:

Panic disorder (PD) is a highly prevalent and debilitating condition. Unfortunately, many people with PD go untreated because of the high cost and low availability of treatment. Research shows that CBT is an effective treatment for PD. When administered as a self-help, computer based treatment, CBT may provide a less expensive, more engaging treatment for PD.

Participants in this study will be randomly assigned to receive computer based treatment, book based treatment, or no treatment for 10 weeks. After these 10 weeks, symptoms of anxiety and depression will be measured with patient interviews, scales, and questionnaires.

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • DSM-IV diagnosis of panic disorder, with or without agoraphobia

Exclusion Criteria:

  • Change in medication type or dose 12 weeks prior to study entry
  • Suicidal
  • Current substance abuse
  • Current or past schizophrenia, bipolar disorder, or organic mental disorder. Patients on medications must meet stability requirements such that initial administration of the medication and dose has been maintained for at least 3 months prior to treatment and will be maintained until post-treatment.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00063375

Locations
United States, Florida
Florida State University
Tallahassee, Florida, United States, 32306
Sponsors and Collaborators
Florida State University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00063375     History of Changes
Other Study ID Numbers: R21 MH62056, R21MH062056, DSIR AT-AS
Study First Received: June 25, 2003
Last Updated: October 24, 2013
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Disease
Panic Disorder
Anxiety Disorders
Mental Disorders
Pathologic Processes

ClinicalTrials.gov processed this record on October 30, 2014